Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: data from three pooled open-label studies
FGF-5 uniquely identifies subjects with heterozygous familial hypercholesterolemia: results from a proteomics study
Global prevalence of overweight and obesity among paediatric and adult patients with homozygous or heterozygous familial hypercholesterolaemia, and association with coronary artery disease
